References
- Araki, E., Lipes, M.A., Patti, M.E., Bruning, J.C., Haag, B. 3rd., Johnson, R.S., and Kahn, C.R.(1994). Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372, 186-190. https://doi.org/10.1038/372186a0
- Bae, C.R., Hasegawa, K., Akieda-Asai, S., Kawasaki, Y., Senba, K., Cha, Y.S., and Date, Y. (2014). Possible involvement of food texture in insulin resistance and energy metabolism in male rats. J. Endocrinol. 222, 61-72. https://doi.org/10.1530/JOE-13-0553
- Benito, M. (2011). Tissue specificity on insulin action and resistance: past to recent mechanisms. Acta Physiol. 201, 297-312. https://doi.org/10.1111/j.1748-1716.2010.02201.x
- Berindan-Neagoe, I., Monroig Pdel, C., Pasculli, B., and Calin, G.A. (2014) MicroRNAome genome: a treasure for cancer diagnosis and therapy. CA Cancer J. Clin. 64, 311-336. https://doi.org/10.3322/caac.21244
- Blaak, E.E. (2005). Metabolic fluxes in skeletal muscle in relation to obesity and insulin resistance. Best Pract. Res. Clin. Endocrinol. Metab. 19, 391-403. https://doi.org/10.1016/j.beem.2005.04.001
- Bruning, J.C., Winnay, J., Cheatham, B., and Kahn, C.R. (1997). Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1-deficient cells. Mol. Cell Biol. 17, 1513-1521. https://doi.org/10.1128/MCB.17.3.1513
- Bu, Y.H., He, Y.L., Zhou, H.D., Liu, W., Peng, D., Tang, A.G., Tang, L.L., Xie, H., Huang, Q.X., Luo, X.H., et al. (2010). Insulin receptor substrate 1 regulates the cellular differentiation and the matrix metallopeptidase expression of preosteoblastic cells. J. Endocrinol. 206, 271-277. https://doi.org/10.1677/JOE-10-0064
- Cheng, C.J., Bahal, R., Babar, I.A., Pincus, Z., Barrera, F., Liu, C., Svoronos, A., Braddock, D.T., Glazer, P.M., Engelman, D.M., et al. (2015). MicroRNA silencing for cancer therapy targeted to the tumour microenvironment. Nature 518, 107-110. https://doi.org/10.1038/nature13905
- Davalos, A., Goedeke, L., Smibert, P., Ramirez, C.M., Warrier, N.P., Andreo, U., Cirera-Salinas, D., Rayner, K., Suresh, U., Pastor-Pareja, J.C., et al. (2011). miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc. Natl. Acad. Sci. USA 108, 9232-9237. https://doi.org/10.1073/pnas.1102281108
- Fang, J.K., Zhou, Y.P., and Li, M.L. (2014). [Research progress on effects of traditional Chinese medicines on proliferation, apoptosis and differentiation of bone marrow mesenchymal stem cells]. Zhongguo Zhong Yao Za Zhi. 39, 2834-2837.
- Fernandez-Hernando, C., Ramirez, C.M., Goedeke, L., and Suarez, Y. (2013). MicroRNAs in metabolic disease. Arterioscler Thromb. Vasc. Biol. 33, 178-185. https://doi.org/10.1161/ATVBAHA.112.300144
- Giudice, A., D'Arena, G., Crispo, A., Tecce, M.F., Nocerino, F., Grimaldi, M., Rotondo, E., D'Ursi, A.M., Scrima, M., Galdiero, M., et al. (2016). Role of viral miRNAs and epigenetic modifications in epsteinbarr virus-associated gastric carcinogenesis. Oxid. Med. Cell Longev. 2016, 6021934.
- Gonzalez-Rodriguez, A., Clampit, J.E., Escribano, O., Benito, M., Rondinone, C.M., and Valverde, A.M. (2007). Developmental switch from prolonged insulin action to increased insulin sensitivity in protein tyrosine phosphatase 1B-deficient hepatocytes. Endocrinology 148, 594-608.30. https://doi.org/10.1210/en.2006-0644
- Guay, C., and Regazzi, R. (2015). MicroRNAs and the functional beta cell mass: for better or worse. Diabetes Metab. 41, 369-377.20. https://doi.org/10.1016/j.diabet.2015.03.006
- Guo, S. (2013). Molecular basis of insulin resistance: The role of IRS and Foxo1 in the control of diabetes mellitus and its complications. Drug Discov. Today Dis. Mech. 10, e27-e33. https://doi.org/10.1016/j.ddmec.2013.06.003
- Guo, S. (2014). Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms. J. Endocrinol. 220, T1-T23. https://doi.org/10.1530/JOE-13-0327
- Guo, Y., Tang, C.Y., Man, X.F., Tang, H.N., Tang, J., Wang, F., Zhou, C.L., Tan, S.W., Feng, Y.Z., and Zhou, H.D. (2016). Insulin receptor substrate-1 time-dependently regulates bone formation by controlling collagen Ialpha2 expression via miR-342. FASEB J. 30, 4214-4226. https://doi.org/10.1096/fj.201600445RR
- Kaburagi, Y., Satoh, S., Tamemoto, H., Yamamoto-Honda, R., Tobe, K., Veki, K., Yamauchi, T., Kono-Sugita, E., Sekihara, H., Aizawa, S., et al. (1997). Role of insulin receptor substrate-1 and pp60 in the regulation of insulin-induced glucose transport and GLUT4 translocation in primary adipocytes. J. Biol. Chem. 272, 25839-25844. https://doi.org/10.1074/jbc.272.41.25839
- Kadowaki, T. (2000). Insights into insulin resistance and type 2 diabetes from knockout mouse models. J. Clin. Invest. 106, 459-465. https://doi.org/10.1172/JCI10830
- Kido, Y., Burks, D.J., Withers, D., Bruning, J.C., Kahn, C.R., White, M.F., and Accili, D. (2000). Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. J. Clin. Invest. 105, 199-205. https://doi.org/10.1172/JCI7917
- Kong, Y.W., Ferland-McCollough, D., Jackson, T.J., and Bushell, M. (2012). microRNAs in cancer management. Lancet Oncol. 13, e249-258. https://doi.org/10.1016/S1470-2045(12)70073-6
- Kubota, N., Terauchi, Y., Tobe, K., Yano, W., Suzuki, R., Ueki, K., Takamoto, I., Satoh, H., Maki, T., Kubota, T., et al. (2004). Insulin receptor substrate 2 plays a crucial role in beta cells and the hypothalamus. J. Clin. Invest. 114, 917-927. https://doi.org/10.1172/JCI21484
- Leibiger, I.B., Leibiger, B., and Berggren, P.O. (2008). Insulin signaling in the pancreatic beta-cell. Annu. Rev. Nutr. 28, 233-251. https://doi.org/10.1146/annurev.nutr.28.061807.155530
- Li, X., and Song, G. (2012). [Roles of matrix metalloproteinase in migration and differentiation of bone marrow-derived mesenchymal stem cells]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 29, 387-391.
- Li, Y., Wang, J., Gu, T., and Yamahara, J. (2014). Oleanolic acid supplement attenuates liquid fructose-induced adipose tissue insulin resistance through the insulin receptor substrate- 1/phosphatidylinositol 3-kinase/Akt signaling pathway in rats. Toxicol. Appl. Pharmacol. 277, 155-163. https://doi.org/10.1016/j.taap.2014.03.016
- Lu, J., Zeng, Y., Hou, W., Zhang, S., Li, L., Luo, X., Xi, W., Chen, Z., and Xiang, M. (2012). The soybean peptide aglycin regulates glucose homeostasis in type 2 diabetic mice via IR/IRS1 pathway. J. Nutr. Biochem. 23, 1449-1457. https://doi.org/10.1016/j.jnutbio.2011.09.007
- Man, X.F., Tan, S.W., Tang, H.N., Guo, Y., Tang, C.Y., Tang, J., Zhou, C.L., and Zhou, H.D. (2016). MiR-503 inhibits adipogenesis by targeting bone morphogenetic protein receptor 1a. Am. J. Transl. Res. 8, 2727-2737.
- Mao, Y., Mohan, R., Zhang, S., and Tang, X. (2013). MicroRNAs as pharmacological targets in diabetes. Pharmacol. Res. 75, 37-47. https://doi.org/10.1016/j.phrs.2013.06.005
- Newsholme, E.A., and Dimitriadis, G. (2001). Integration of biochemical and physiologic effects of insulin on glucose metabolism. Exp. Clin. Endocrinol. Diabetes 109, S122-134. https://doi.org/10.1055/s-2001-18575
- Papaetis, G.S., Papakyriakou, P., and Panagiotou, T.N. (2015). Central obesity, type 2 diabetes and insulin: exploring a pathway full of thorns. Arch. Med. Sci. 11, 463-482.
- Patti, M.E., Sun, X.J., Bruening, J.C., Araki, E., Lipes, M.A., White, M.F., and Kahn, C.R. (1995). 4PS/insulin receptor substrate (IRS)-2 is the alternative substrate of the insulin receptor in IRS-1-deficient mice. J. Biol. Chem. 270, 24670-24673. https://doi.org/10.1074/jbc.270.42.24670
- Rebustini, I.T., Vlahos, M., Packer, T., Kukuruzinska, M.A., and Maas, R.L. (2016). An integrated miRNA functional screening and target validation method for organ morphogenesis. Sci. Rep. 6, 23215. https://doi.org/10.1038/srep23215
- Richardson, K., Nettleton, J.A., Rotllan, N., Tanaka, T., Smith, C.E., Lai, C.Q., Parnell, L.D., Lee, Y.C., Lahti, J., Lemaitre, R.N., et al. (2013). Gain-of-function lipoprotein lipase variant rs13702 modulates lipid traits through disruption of a microRNA-410 seed site. Am. J. Hum. Genet. 92, 5-14. https://doi.org/10.1016/j.ajhg.2012.10.020
- Rondinone, C.M., Wang, L.M., Lonnroth, P., Wesslau, C., Pierce, J.H., and Smith, U. (1997). Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA 94, 4171-4175. https://doi.org/10.1073/pnas.94.8.4171
- Rui, L. (2014). Energy metabolism in the liver. Compr. Physiol. 4, 177-197.
- Sawka-Verhelle, D., Tartare-Deckert, S., White, M.F., and Van Obberghen, E. (1996). Insulin receptor substrate-2 binds to the insulin receptor through its phosphotyrosine-binding domain and through a newly identified domain comprising amino acids 591-786. J. Biol. Chem. 271, 5980-5983. https://doi.org/10.1074/jbc.271.11.5980
- Sesti, G., Federici, M., Hribal., M.L., Lauro, D., Sbraccia, P., and Lauro, R. (2001). Defects of the insulin receptor substrate (IRS) system in human metabolic disorders. FASEB J. 15, 2099-2111. https://doi.org/10.1096/fj.01-0009rev
- Simmons, J.G., Ling, Y., Wilkins, H., Fuller, C.R., D'Ercole, A.J., Fagin, J., and Lund, P.K. (2007). Cell-specific effects of insulin receptor substrate-1 deficiency on normal and IGF-I-mediated colon growth. Am. J. Physiol. Gastrointest Liver Physiol. 293, G995-1003. https://doi.org/10.1152/ajpgi.00537.2006
- Sun, X.J., Wang, L.M., Zhang, Y., Yenush, L., Myers, M.G., Jr., Glasheen, E., Lane, W.S., Pierce, J.H., and White, M.F. (1995). Role of IRS-2 in insulin and cytokine signaling. Nature 377, 173-177. https://doi.org/10.1038/377173a0
- Valverde, A.M., Lorenzo, M., Pons, S., White, M.F., and Benito, M. (1998). Insulin receptor substrate (IRS) proteins IRS-1 and IRS-2 differential signaling in the insulin/insulin-like growth factor-I pathways in fetal brown adipocytes. Mol. Endocrinol. 12, 688-697. https://doi.org/10.1210/mend.12.5.0106
- White, M.F. (2003). Insulin signaling in health and disease. Science 302, 1710-1711. https://doi.org/10.1126/science.1092952
- Withers, D.J.., Gutierrez, J.S., Towery, H., Burks, D.J., Ren, J.M., Previs, S., Zhang, Y., Bernal, D., Pons, S., Shulman, G.I., et al. (1998). Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391, 900-904. https://doi.org/10.1038/36116
- Zhang, J., and Liu, F. (2014). Tissue-specific insulin signaling in the regulation of metabolism and aging. IUBMB Life 66, 485-495. https://doi.org/10.1002/iub.1293
- Zhou, L., Chen, H., Xu, P., Cong, L.N., Sciacchitano, S., Li, Y., Graham, D., Jacobs, A.R., Taylor, S.I., and Quon, M.J. (1999). Action of insulin receptor substrate-3 (IRS-3) and IRS-4 to stimulate translocation of GLUT4 in rat adipose cells. Mol. Endocrinol. 13, 505-514. https://doi.org/10.1210/mend.13.3.0242
Cited by
- The Role of Insulin-Like Growth Factor 1 in the Progression of Age-Related Hearing Loss vol.9, pp.1663-4365, 2017, https://doi.org/10.3389/fnagi.2017.00411
- T cells by elevating IRS-1 pathway pp.00099104, 2017, https://doi.org/10.1111/cei.13067
- MicroRNAs as Regulators of Insulin Signaling: Research Updates and Potential Therapeutic Perspectives in Type 2 Diabetes vol.19, pp.12, 2018, https://doi.org/10.3390/ijms19123705
- Glucose Controls the Expression of Polypyrimidine Tract-Binding Protein 1 via the Insulin Receptor Signaling Pathway in Pancreatic β Cells vol.41, pp.10, 2017, https://doi.org/10.14348/molcells.2018.0147
- The role of microRNAs in the regulation of insulin signaling pathway with respect to metabolic and mitogenic cascades: A review vol.120, pp.12, 2017, https://doi.org/10.1002/jcb.29299
- Insulin Signaling in Bone Marrow Adipocytes vol.17, pp.6, 2017, https://doi.org/10.1007/s11914-019-00552-8
- Serum miR-503 is a Candidate Biomarker for Differentiating Metabolic Healthy Obesity from Metabolic Unhealthy Obesity vol.13, pp.None, 2017, https://doi.org/10.2147/dmso.s262888
- Insulin receptor substrate‐1 inhibits high‐fat diet‐induced obesity by browning of white adipose tissue through miR‐503 vol.34, pp.9, 2017, https://doi.org/10.1096/fj.201903283rr
- Impact of insulin and glucocorticoid signalling on hepatic glucose homeostasis in the rat exposed to high-fructose diet and chronic stress vol.71, pp.7, 2020, https://doi.org/10.1080/09637486.2020.1728236
- miR‐124‐3p increases in high glucose induced osteocyte‐derived exosomes and regulates galectin‐3 expression: A possible mechanism in bone remodeling alteration in diabetic vol.34, pp.11, 2017, https://doi.org/10.1096/fj.202000970rr
- SHP2 knockdown ameliorates liver insulin resistance by activating IRS‐2 phosphorylation through the AKT and ERK1/2 signaling pathways vol.10, pp.12, 2017, https://doi.org/10.1002/2211-5463.12992
- The Yin and Yang function of microRNAs in insulin signalling and cancer vol.18, pp.1, 2021, https://doi.org/10.1080/15476286.2020.1804236
- miR‐33 in cardiometabolic diseases: lessons learned from novel animal models and approaches vol.13, pp.5, 2017, https://doi.org/10.15252/emmm.202012606
- Accurate diagnosis and heterogeneity analysis of a 17q12 deletion syndrome family with adulthood diabetes onset and complex clinical phenotypes vol.73, pp.1, 2017, https://doi.org/10.1007/s12020-021-02682-5